| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Research Abstract |
XIAP, which is involved in resistances for anticancer drugs and irradiation, is an attractive target for the development of new anticancer drugs. In this study, we attempted to create novel lead compounds for new anticancer drugs. As a result, we could discover a novel agonistic compound, which possess a good binding form to XIAP.
|
